
Ingrid Binswanger
Director of Substance Use and Harm Reduction Research Development for General Internal Medicine · University of Colorado School of Medicine
Credentials: · · · · ·
History
- Present
Substance Use and Harm Reduction Research Development for General Internal Medicine · University of Colorado School of Medicine
Research
Release from prison--a high risk of death for former inmates
New England Journal of Medicine · 2007 · First of 7 authors · Corresponding · 1,130 citations
Journal of Epidemiology & Community Health · 2009 · First of 3 authors · Corresponding · 513 citations
Meta-analysis of drug-related deaths soon after release from prison
Systematic review or meta-analysis · Addiction · 2010 · 502 citations

20 papers · 1 as a fellow
- BA
14 papers
- DS
11 papers

11 papers

9 papers

9 papers

9 papers

8 papers
Grants
- 2015–2032
Health Systems Node of the NIDA Clinical Trials Network
National Institute on Drug Abuse · UG1
PI · $2.4M · Kaiser Foundation Research Institute
- 2019–2023
Assessing the Safety and Effectiveness of Opioid Tapering in Large Health Systems
National Institute on Drug Abuse · R01
Contact PI · $2.6M · Kaiser Foundation Research Institute
- 2016–2022
The Safety and Impact of Expanded Access to Naloxone in Health Systems
National Institute on Drug Abuse · R01
Contact PI · $3.6M · Kaiser Foundation Research Institute
- 2017–2019
Assessing the Unintended Consequences of Restrictive Opioid Pain Reliever Policies
NCIPC · U01
Contact PI · $799.7K · Kaiser Foundation Research Institute
Clinical trials
- 2023–2026
Health Insurance Instability and Mortality Among Patients Receiving Bup Tx for OUD
Principal investigator · Active not recruiting
Kaiser Permanente
- 2020–2024
- 2017–2024
Principal investigator · Unknown
Kaiser Permanente
- 2017–2022
The Impact of Co-Dispensing Naloxone to Patients Prescribed Chronic Opioid Therapy
Principal investigator · Completed
Kaiser Permanente


